Skip to content

Insider · CIK 0001620611

Pellegrini Niamh Louise

Reports to the SEC for 3 companies · PLEASANTON, CA

Transactions

50

Companies

3

Filings

14

CIK

0001620611

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2023-06-15Acutus Medical, Inc.A Award—
2023-06-15Acutus Medical, Inc.FORM 4A Award—
2023-05-28NEVRO CORPF Tax Payment−$30.2K
2023-03-07NEVRO CORPA Award—
2023-03-02NEVRO CORPF Tax Payment−$67.3K
2023-02-28NEVRO CORPF Tax Payment−$148K
2022-08-06NEVRO CORPF Tax Payment−$206K
2022-06-16Acutus Medical, Inc.A Award—
2022-06-16Acutus Medical, Inc.Stock Options (Right to Buy)A Award—
2022-03-02NEVRO CORPF Tax Payment−$145K
2022-02-28NEVRO CORPA Award—
2021-08-10Acutus Medical, Inc.A Award—
2021-08-10Acutus Medical, Inc.Stock Options (Right to Buy)A Award—
2021-08-06NEVRO CORPF Tax Payment−$523K
2021-03-10NEVRO CORPM Exercise/Conversion+$48.7K
2021-03-10NEVRO CORPS Sale−$111K
2021-03-10NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion—
2021-03-02NEVRO CORPA Award—
2021-03-02NEVRO CORPF Tax Payment−$119K
2021-02-10NEVRO CORPM Exercise/Conversion+$48.7K
2021-02-10NEVRO CORPS Sale−$137K
2021-02-10NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion—
2021-01-11NEVRO CORPM Exercise/Conversion+$48.7K
2021-01-11NEVRO CORPS Sale−$127K
2021-01-11NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion—
2020-12-10NEVRO CORPM Exercise/Conversion+$48.7K
2020-12-10NEVRO CORPS Sale−$48.6K
2020-12-10NEVRO CORPS Sale−$72.3K
2020-12-10NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion—
2020-11-10NEVRO CORPM Exercise/Conversion+$48.7K
2020-11-10NEVRO CORPS Sale−$128K
2020-11-10NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion—
2020-10-22NEVRO CORPS Sale−$300K
2020-10-19NEVRO CORPS Sale−$155K
2020-10-13NEVRO CORPM Exercise/Conversion+$48.7K
2020-10-13NEVRO CORPS Sale−$114K
2020-10-13NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion—
2020-10-09NEVRO CORPS Sale−$150K
2020-09-10NEVRO CORPM Exercise/Conversion+$48.7K
2020-09-10NEVRO CORPS Sale−$104K
2020-09-10NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion—
2020-08-10NEVRO CORPM Exercise/Conversion+$48.7K
2020-08-10NEVRO CORPS Sale−$105K
2020-08-10NEVRO CORPStock Option (Right to Buy)M Exercise/Conversion—
2020-08-06NEVRO CORPF Tax Payment−$635K
2020-03-02NEVRO CORPA Award—
2019-07-15NEVRO CORPA Award—
2019-07-15NEVRO CORPStock Option (Right to Buy)A Award—
2015-10-08THORATEC CORPA Award—
2015-10-08THORATEC CORPD Disposition to Issuer−$3.3M

Recent filings

14